Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA – Get Free Report) VP Brendan Luu sold 2,125 shares of the stock in a transaction that occurred on Tuesday, December 5th. The stock was sold at an average price of $9.63, for a total value of $20,463.75. Following the sale, the vice president now directly owns 36,736 shares in the […]
Related Keywords
Brendan Luu ,Enanta Pharmaceuticals Inc ,Enanta Pharmaceuticals Stock Performance ,Krensavage Asset Management ,Jpmorgan Chase Co ,Securities Exchange Commission ,Enanta Pharmaceuticals ,Quarter For Enanta Pharmaceuticals ,News Ratings For Enanta Pharmaceuticals Daily ,Acadian Asset Management ,Nasdaq ,Get Free Report ,Exchange Commission ,Asset Management ,State Street Corp ,Street Corp ,Enanta Pharmaceuticals Daily ,Nasdaq Enta ,Enta ,Medical ,Insider Trading ,Nsider Trades ,Stocks ,
comparemela.com © 2020. All Rights Reserved.